HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Penetration of tinidazole into skin blister fluid following its oral administration.

Abstract
Plasma and skin blister fluid concentrations of tinidazole following a single oral dose of 2 g drug, and after multiple doses of 0.25 g every 12 h, were determined. Skin blisters were produced by direct application of 0.25% cantharidin ointment to the skin. The maximum concentration in plasma of about 36 mg.l-1 was observed after about 2 h, whereas in skin blister fluid the peak occurred after about 6 h and was 30 mg.l-1. The half-life in plasma was slightly shorter than in blister fluid at 17 and 19 h, respectively, but the difference was not significant. The penetration of tinidazole into cantharidin-induced skin blister fluid, defined according to Wise as the ratio of the AUCs in blister fluid and plasma was 1.00. During routine treatment with tinidazole (0.25 g every 12 h), the concentrations in plasma and blister fluid collected before and 3 h after the morning dose exceeded the minimal inhibitory concentrations for susceptible pathogens. The results provide a pharmacokinetic basis for the proven efficacy of tinidazole in the treatment of protozoal and anaerobic infections.
AuthorsA Klimowicz, A Nowak, S Bielecka-Grzela
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 43 Issue 5 Pg. 523-6 ( 1992) ISSN: 0031-6970 [Print] Germany
PMID1483489 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tinidazole
Topics
  • Administration, Oral
  • Adult
  • Blister (metabolism)
  • Body Fluids (metabolism)
  • Dermatitis, Seborrheic (blood, drug therapy, metabolism)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tinidazole (administration & dosage, blood, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: